Literature DB >> 3536982

Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man.

B J Wallum, G J Taborsky, D Porte, D P Figlewicz, L Jacobson, J C Beard, W K Ward, D Dorsa.   

Abstract

We hypothesized that plasma insulin crosses the blood-cerebrospinal fluid (CSF) barrier and, as people gain weight, provides a physiological feedback signal to the central nervous system to inhibit food intake and further weight gain. However, it has not been demonstrated in man that insulin can enter the CSF from peripheral blood. To test whether increases in plasma insulin result in elevated CSF immunoreactive insulin (IRI) levels, we infused insulin iv in varying amounts approximating postprandial levels in eight normal subjects for 4.5 h. Euglycemia was maintained [88 +/- 3 (+/- SEM) mg/dl] by means of a variable glucose infusion. Samples were obtained every 30 min for measurements of insulin in peripheral plasma and insulin in lumbar CSF. Plasma IRI increased from a mean basal level of 12 +/- 1.2 microU/ml to a mean (during the 180- to 270-minute period) of 268 +/- 35 microU/ml. CSF IRI increased in all subjects during the infusion from a mean basal level of 0.9 +/- 0.1 microU/ml to a mean (during the 180- to 270-min period) of 2.8 +/- 0.4 microU/ml (P less than 0.006). By contrast, CSF IRI in two subjects who received an infusion of 0.9% saline did not increase. In summary, CSF insulin concentrations increased during peripheral infusions of insulin. This is the first demonstration in man that plasma insulin gains access to CSF and indicates a mechanism whereby peripheral insulin could provide a feedback signal to the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3536982     DOI: 10.1210/jcem-64-1-190

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  62 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.

Authors:  D S Quintana; A J Guastella; L T Westlye; O A Andreassen
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

3.  Low cerebrospinal fluid insulin levels in obese humans.

Authors:  W Kern; C Benedict; B Schultes; F Plohr; A Moser; J Born; H L Fehm; M Hallschmid
Journal:  Diabetologia       Date:  2006-09-02       Impact factor: 10.122

4.  Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport.

Authors:  M W Schwartz; R N Bergman; S E Kahn; G J Taborsky; L D Fisher; A J Sipols; S C Woods; G M Steil; D Porte
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

Review 5.  Insulin and insulin-like growth factor receptors in the nervous system.

Authors:  M Adamo; M K Raizada; D LeRoith
Journal:  Mol Neurobiol       Date:  1989 Spring-Summer       Impact factor: 5.590

6.  Diabetes and the elderly brain: sweet memories?

Authors:  Katherine Samaras; Perminder S Sachdev
Journal:  Ther Adv Endocrinol Metab       Date:  2012-12       Impact factor: 3.565

7.  Effect of ID ACE gene polymorphism on dietary composition and obesity-related anthropometric parameters in the Czech adult population.

Authors:  Julie Bienertova-Vasku; Petr Bienert; Lenka Sablikova; Lenka Slovackova; Martin Forejt; Zlata Piskackova; Lenka Kucerova; Katerina Heczkova; Zuzana Brazdova; Anna Vasku
Journal:  Genes Nutr       Date:  2009-07-16       Impact factor: 5.523

8.  Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain.

Authors:  G D Baura; D M Foster; D Porte; S E Kahn; R N Bergman; C Cobelli; M W Schwartz
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo.

Authors:  Sachin A Paranjape; Owen Chan; Wanling Zhu; Adam M Horblitt; Ewan C McNay; James A Cresswell; Jonathan S Bogan; Rory J McCrimmon; Robert S Sherwin
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

10.  Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors.

Authors:  Massimo Musicco; Katie Palmer; Giovanna Salamone; Federica Lupo; Roberta Perri; Serena Mosti; Gianfranco Spalletta; Fulvia di Iulio; Carla Pettenati; Luca Cravello; Carlo Caltagirone
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.